BDNF-secreting capsule exerts neuroprotective effects on epilepsy model of rats

Satoshi Kuramoto, Takao Yasuhara, Takashi Agari, Akihiko Kondo, Meng Jing, Yoichiro Kikuchi, Aiko Shinko, Takaaki Wakamori, Masahiro Kameda, Feifei Wang, Kyohei Kin, Satoru Edahiro, Yasuyuki Miyoshi, Isao Date

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Brain-derived neurotrophic factor (BDNF) is a well neurotrophic factor with neuroprotective potentials for various diseases in the central nervous system. However several previous studies demonstrated that BDNF might deteriorate symptoms for epilepsy model of animals by progression of abnormal neurogenesis. We hypothesized that continuous administration of BDNF at low dose might be more effective for epilepsy model of animals because high dose of BDNF was used in many studies. BDNF-secreting cells were genetically made and encapsulated for transplantation. Rats receiving BDNF capsule showed significant amelioration of seizure stage and reduction of the number of abnormal spikes at 7 days after kainic acid administration, compared to those of control group. The number of BrdU and BrdU/doublecortin positive cells in the hippocampus of BDNF group significantly increased, compared to that of control group. NeuN positive cells in the CA1 and CA3 of BDNF group were significantly preserved, compared to control group. In conclusion, low dose administration using encapsulated BDNF-secreting cells exerted neuroprotective effects with enhanced neurogenesis on epilepsy model of rats. These results might suggest the importance of the dose and administrative way of this neurotrophic factor to the epilepsy model of animals.

Original languageEnglish
Pages (from-to)281-289
Number of pages9
JournalBrain Research
Volume1368
DOIs
Publication statusPublished - Jan 12 2011

Fingerprint

Brain-Derived Neurotrophic Factor
Neuroprotective Agents
Capsules
Epilepsy
Animal Models
Neurogenesis
Nerve Growth Factors
Bromodeoxyuridine
Control Groups
Kainic Acid
Central Nervous System Diseases
Hippocampus
Seizures
Transplantation

Keywords

  • Brain-derived neurotrophic factor
  • Epilepsy
  • Ex vivo gene therapy
  • Kainic acid
  • Neurogenesis
  • Neuroprotection

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Developmental Biology
  • Molecular Biology

Cite this

BDNF-secreting capsule exerts neuroprotective effects on epilepsy model of rats. / Kuramoto, Satoshi; Yasuhara, Takao; Agari, Takashi; Kondo, Akihiko; Jing, Meng; Kikuchi, Yoichiro; Shinko, Aiko; Wakamori, Takaaki; Kameda, Masahiro; Wang, Feifei; Kin, Kyohei; Edahiro, Satoru; Miyoshi, Yasuyuki; Date, Isao.

In: Brain Research, Vol. 1368, 12.01.2011, p. 281-289.

Research output: Contribution to journalArticle

Kuramoto, S, Yasuhara, T, Agari, T, Kondo, A, Jing, M, Kikuchi, Y, Shinko, A, Wakamori, T, Kameda, M, Wang, F, Kin, K, Edahiro, S, Miyoshi, Y & Date, I 2011, 'BDNF-secreting capsule exerts neuroprotective effects on epilepsy model of rats', Brain Research, vol. 1368, pp. 281-289. https://doi.org/10.1016/j.brainres.2010.10.054
Kuramoto, Satoshi ; Yasuhara, Takao ; Agari, Takashi ; Kondo, Akihiko ; Jing, Meng ; Kikuchi, Yoichiro ; Shinko, Aiko ; Wakamori, Takaaki ; Kameda, Masahiro ; Wang, Feifei ; Kin, Kyohei ; Edahiro, Satoru ; Miyoshi, Yasuyuki ; Date, Isao. / BDNF-secreting capsule exerts neuroprotective effects on epilepsy model of rats. In: Brain Research. 2011 ; Vol. 1368. pp. 281-289.
@article{57f51bea51dd43bc89caf315df6dd599,
title = "BDNF-secreting capsule exerts neuroprotective effects on epilepsy model of rats",
abstract = "Brain-derived neurotrophic factor (BDNF) is a well neurotrophic factor with neuroprotective potentials for various diseases in the central nervous system. However several previous studies demonstrated that BDNF might deteriorate symptoms for epilepsy model of animals by progression of abnormal neurogenesis. We hypothesized that continuous administration of BDNF at low dose might be more effective for epilepsy model of animals because high dose of BDNF was used in many studies. BDNF-secreting cells were genetically made and encapsulated for transplantation. Rats receiving BDNF capsule showed significant amelioration of seizure stage and reduction of the number of abnormal spikes at 7 days after kainic acid administration, compared to those of control group. The number of BrdU and BrdU/doublecortin positive cells in the hippocampus of BDNF group significantly increased, compared to that of control group. NeuN positive cells in the CA1 and CA3 of BDNF group were significantly preserved, compared to control group. In conclusion, low dose administration using encapsulated BDNF-secreting cells exerted neuroprotective effects with enhanced neurogenesis on epilepsy model of rats. These results might suggest the importance of the dose and administrative way of this neurotrophic factor to the epilepsy model of animals.",
keywords = "Brain-derived neurotrophic factor, Epilepsy, Ex vivo gene therapy, Kainic acid, Neurogenesis, Neuroprotection",
author = "Satoshi Kuramoto and Takao Yasuhara and Takashi Agari and Akihiko Kondo and Meng Jing and Yoichiro Kikuchi and Aiko Shinko and Takaaki Wakamori and Masahiro Kameda and Feifei Wang and Kyohei Kin and Satoru Edahiro and Yasuyuki Miyoshi and Isao Date",
year = "2011",
month = "1",
day = "12",
doi = "10.1016/j.brainres.2010.10.054",
language = "English",
volume = "1368",
pages = "281--289",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

TY - JOUR

T1 - BDNF-secreting capsule exerts neuroprotective effects on epilepsy model of rats

AU - Kuramoto, Satoshi

AU - Yasuhara, Takao

AU - Agari, Takashi

AU - Kondo, Akihiko

AU - Jing, Meng

AU - Kikuchi, Yoichiro

AU - Shinko, Aiko

AU - Wakamori, Takaaki

AU - Kameda, Masahiro

AU - Wang, Feifei

AU - Kin, Kyohei

AU - Edahiro, Satoru

AU - Miyoshi, Yasuyuki

AU - Date, Isao

PY - 2011/1/12

Y1 - 2011/1/12

N2 - Brain-derived neurotrophic factor (BDNF) is a well neurotrophic factor with neuroprotective potentials for various diseases in the central nervous system. However several previous studies demonstrated that BDNF might deteriorate symptoms for epilepsy model of animals by progression of abnormal neurogenesis. We hypothesized that continuous administration of BDNF at low dose might be more effective for epilepsy model of animals because high dose of BDNF was used in many studies. BDNF-secreting cells were genetically made and encapsulated for transplantation. Rats receiving BDNF capsule showed significant amelioration of seizure stage and reduction of the number of abnormal spikes at 7 days after kainic acid administration, compared to those of control group. The number of BrdU and BrdU/doublecortin positive cells in the hippocampus of BDNF group significantly increased, compared to that of control group. NeuN positive cells in the CA1 and CA3 of BDNF group were significantly preserved, compared to control group. In conclusion, low dose administration using encapsulated BDNF-secreting cells exerted neuroprotective effects with enhanced neurogenesis on epilepsy model of rats. These results might suggest the importance of the dose and administrative way of this neurotrophic factor to the epilepsy model of animals.

AB - Brain-derived neurotrophic factor (BDNF) is a well neurotrophic factor with neuroprotective potentials for various diseases in the central nervous system. However several previous studies demonstrated that BDNF might deteriorate symptoms for epilepsy model of animals by progression of abnormal neurogenesis. We hypothesized that continuous administration of BDNF at low dose might be more effective for epilepsy model of animals because high dose of BDNF was used in many studies. BDNF-secreting cells were genetically made and encapsulated for transplantation. Rats receiving BDNF capsule showed significant amelioration of seizure stage and reduction of the number of abnormal spikes at 7 days after kainic acid administration, compared to those of control group. The number of BrdU and BrdU/doublecortin positive cells in the hippocampus of BDNF group significantly increased, compared to that of control group. NeuN positive cells in the CA1 and CA3 of BDNF group were significantly preserved, compared to control group. In conclusion, low dose administration using encapsulated BDNF-secreting cells exerted neuroprotective effects with enhanced neurogenesis on epilepsy model of rats. These results might suggest the importance of the dose and administrative way of this neurotrophic factor to the epilepsy model of animals.

KW - Brain-derived neurotrophic factor

KW - Epilepsy

KW - Ex vivo gene therapy

KW - Kainic acid

KW - Neurogenesis

KW - Neuroprotection

UR - http://www.scopus.com/inward/record.url?scp=78651076964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651076964&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2010.10.054

DO - 10.1016/j.brainres.2010.10.054

M3 - Article

C2 - 20971090

AN - SCOPUS:78651076964

VL - 1368

SP - 281

EP - 289

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -